N Engl J Med 341:879884 Roth CL, Scimia C, Shoemaker AH et al (2024) Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
Reconocida como uno de los avances ms prometedores en el campo de la salud metablica , la retatrutida ofrece un enfoque integral para el manejo del peso
I will say, she is right, you do have to give it the 12 weeks for your natural mitochondria cycle to turn over (your cells that repair your body, and in this case, skin), but omg what a difference
The five qualifying conditions The five qualifying conditions for the NHS pathway under NICE TA1026 are 4 : Type 2 diabetes High blood pressure (hypertension) Cardiovascular disease (previous heart attack, stroke, angina, or coronary procedure) High cholesterol or dyslipidaemia Obstructive sleep apnoea For the private route, the Mounjaro and Wegovy product licences accept any one of these, plus prediabetes (an HbA1c blood-sugar reading between 42 and 47 mmol/mol) 1,2